LATIN AMERICA BOTULINUM TOXIN MARKET 2021-2028

 

 

TABLE OF CONTENTS

 

1.     LATIN AMERICA BOTULINUM TOXIN MARKET – SUMMARY 

2.     INDUSTRY OUTLOOK

1.1. KEY INSIGHTS     

1.1.1.    SURGE IN DISPOSABLE INCOME       

1.1.2.    GROWING NUMBER OF MEN OPTING FOR COSMETIC TREATMENT  

1.1.3.    DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE    

1.1. IMPACT OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY 

1.2. PORTER’S FIVE FORCES ANALYSIS 

1.1.1.    THREAT OF NEW ENTRANTS   

1.1.2.    THREAT OF SUBSTITUTE         

1.1.3.    BARGAINING POWER OF SUPPLIERS

1.1.4.    BARGAINING POWER OF BUYERS     

1.1.5.    THREAT OF COMPETITIVE RIVALRY  

1.1. MARKET ATTRACTIVENESS MATRIX

1.2. VENDOR SCORECARD  

1.3. KEY MARKET STRATEGIES     

1.1.1.    NEW PRODUCT LAUNCHES     

1.1. MARKET DRIVERS         

1.1.1.    INCREASING DEMAND FOR AESTHETIC PROCEDURES 

1.1.2.    EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS        

1.1. MARKET RESTRAINTS   

1.1.1.    ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN  

1.1.2.    LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES 

1.1.3.    LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS   

1.1. MARKET OPPORTUNITIES      

1.1.1.    INCREASING AGING POPULATION    

1.1.2.    RISE IN MEDICAL TOURISM     

2.     LATIN AMERICA BOTULINUM TOXIN MARKET – BY TYPE    

1.1. TYPE A      

1.2. TYPE B      

2.     LATIN AMERICA BOTULINUM TOXIN MARKET – BY APPLICATION 

1.1. COSMETIC APPLICATIONS      

1.1.1.    GLABELLAR LINES         

1.1.2.    LATERAL CANTHAL LINES (CROW’S FEET) 

1.1.3.    FOREHEAD LINES

1.1.4.    OTHER COSMETIC APPLICATIONS    

1.1. NON-COSMETIC APPLICATIONS       

1.1.1.    DYSTONIA  

1.1.2.    CHRONIC MIGRAINE      

1.1.3.    OPHTHALMOLOGIC DISORDERS       

1.1.4.    OTHER NON-COSMETIC APPLICATIONS     

2.     LATIN AMERICA BOTULINUM TOXIN MARKET –  BY END-USER     

1.1. HOSPITALS

1.2. CLINICS AND OTHERS  

2.     LATIN AMERICA BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK                        

1.1. COUNTRY ANALYSIS     

1.1.1.    BRAZIL        

1.1.2.    MEXICO      

1.1.3.    REST OF LATIN AMERICA                  

2.     COMPETITIVE LANDSCAPE 

1.1. ABBVIE INC

1.2. EVOLUS INC

1.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)     

1.4. HUGEL INC

1.5. IPSEN PHARMA   

1.6. MERZ PHARMA    

1.7. MEDYTOX INC

1.8. REVANCE THERAPEUTICS INC

1.9. US WORLDMEDS LLC    

2.     METHODOLOGY & SCOPE  

1.1. RESEARCH SCOPE & DELIVERABLES        

1.2. SOURCES OF DATA      

1.3. RESEARCH METHODOLOGY  

 

 

LIST OF TABLES

 

TABLE 1: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF NEW PRODUCT LAUNCHES

TABLE 5: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6: LATIN AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 8: LATIN AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 9: LATIN AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

 

LIST OF FIGURES

 

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028

FIGURE 3: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 4: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 5: LATIN AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028

FIGURE 6: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 7: LATIN AMERICA BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 8: LATIN AMERICA BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 9: LATIN AMERICA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 10: LATIN AMERICA BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 11: LATIN AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 12: LATIN AMERICA BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 13: LATIN AMERICA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 14: LATIN AMERICA BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 15: LATIN AMERICA BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 16: LATIN AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028

FIGURE 17: LATIN AMERICA BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 18: LATIN AMERICA BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 19: LATIN AMERICA BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 20: BRAZIL BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 21: MEXICO BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 22: REST OF LATIN AMERICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

 

 

MARKET OUTLOOK

 

The Latin America botulinum toxin market has been projected to develop with a CAGR of 5.48% over the forecasting phase 2021-2028, as per a report by Triton Market Research. Brazil, Mexico, and Rest of Latin America together comprise the market in this region.

Mexico has become a popular destination for medical tourism, given the excellence & skills of its medical professionals, well-developed healthcare infrastructure equipped with the latest technologies, and budget-friendly costs. Therefore, one can avail affordable cosmetic treatment in Mexico, with the same level of expertise that is provided in the developed nations of the US and the UK.

These factors have increased the number of non-surgical procedures being performed in the country, over the past couple of years. According to the ISAPS Report, close to 525,200 non-surgical cosmetic procedures were performed in Mexico in 2018.

Also, botulinum toxin-based procedures were the most commonly performed injectable procedures. The ever-changing trends and the growing consciousness regarding beauty & personal care among Mexicans, along with the rise in people’s disposable income, are some of the growth opportunities that market players can leverage.

Other than these factors, Mexico is a member of the NAFTA, has a friendly regulatory environment, and enjoys import-free duties from the US- and Canada-based companies. All these factors are expected to collectively boost the adoption of botulinum toxin in the nation. This, in turn, will fuel the growth of the studied market, during the forecasting period.

 

 

COMPETITIVE OUTLOOK

 

The dominant companies in the botulinum toxin market are Ipsen Pharma, Revance Therapeutics Inc, Evolus Inc, Merz Pharma, and Abbvie Inc (Allergan Plc).

 

Get more insights into the Latin America Botulinum Toxin Market:

 

https://www.tritonmarketresearch.com/reports/latin-america-botulinum-toxin-market

 

 

SEGMENTATION

 

1.     ABBVIE INC     

2.     EVOLUS INC

3.     GALDERMA PHARMA SA (ACQUIRED BY EQT) 

4.     HUGEL INC

5.     IPSEN PHARMA         

6.     MERZ PHARMA

7.     MEDYTOX INC

8.     REVANCE THERAPEUTICS INC

9.     US WORLDMEDS LLC